Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Return on Equity (2016 - 2021)

Historic Return on Equity for Phio Pharmaceuticals (PHIO) over the last 10 years, with Q3 2021 value amounting to 0.09%.

  • Phio Pharmaceuticals' Return on Equity rose 4500.0% to 0.09% in Q3 2021 from the same period last year, while for Sep 2021 it was 0.09%, marking a year-over-year increase of 4500.0%. This contributed to the annual value of 0.94% for FY2020, which is 200.0% down from last year.
  • As of Q3 2021, Phio Pharmaceuticals' Return on Equity stood at 0.09%, which was up 4500.0% from 0.16% recorded in Q2 2021.
  • Phio Pharmaceuticals' 5-year Return on Equity high stood at 0.09% for Q3 2021, and its period low was 7.69% during Q1 2018.
  • Its 5-year average for Return on Equity is 1.77%, with a median of 0.96% in 2018.
  • In the last 5 years, Phio Pharmaceuticals' Return on Equity tumbled by -64100bps in 2018 and then skyrocketed by 71200bps in 2019.
  • Phio Pharmaceuticals' Return on Equity (Quarter) stood at 4.73% in 2017, then skyrocketed by 80bps to 0.96% in 2018, then plummeted by -40bps to 1.35% in 2019, then surged by 54bps to 0.62% in 2020, then surged by 85bps to 0.09% in 2021.
  • Its last three reported values are 0.09% in Q3 2021, 0.16% for Q2 2021, and 0.29% during Q1 2021.